309 related articles for article (PubMed ID: 11832452)
1. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer.
Hashida H; Takabayashi A; Kanai M; Adachi M; Kondo K; Kohno N; Yamaoka Y; Miyake M
Gastroenterology; 2002 Feb; 122(2):376-86. PubMed ID: 11832452
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma.
Ikeda N; Nakajima Y; Tokuhara T; Hattori N; Sho M; Kanehiro H; Miyake M
Clin Cancer Res; 2003 Apr; 9(4):1503-8. PubMed ID: 12684426
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of aminopeptidase N in non-small cell lung cancer.
Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M
Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694
[TBL] [Abstract][Full Text] [Related]
4. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma.
Otsuki T; Nakashima T; Hamada H; Takayama Y; Akita S; Masuda T; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Miyake M; Kohno N; Okada M; Hattori N
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29519924
[TBL] [Abstract][Full Text] [Related]
5. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.
Bhagwat SV; Lahdenranta J; Giordano R; Arap W; Pasqualini R; Shapiro LH
Blood; 2001 Feb; 97(3):652-9. PubMed ID: 11157481
[TBL] [Abstract][Full Text] [Related]
6. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N
Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis.
Bhagwat SV; Petrovic N; Okamoto Y; Shapiro LH
Blood; 2003 Mar; 101(5):1818-26. PubMed ID: 12406907
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
Ranogajec I; Jakić-Razumović J; Puzović V; Gabrilovac J
Med Oncol; 2012 Jun; 29(2):561-9. PubMed ID: 21611838
[TBL] [Abstract][Full Text] [Related]
9. The novel monoclonal antibody MH8-4 inhibiting cell motility recognizes integrin alpha 3: inverse of its expression withmetastases in colon cancer.
Hashida H; Takabayashi A; Adachi M; Imai T; Kondo K; Kohno N; Yamaoka Y; Miyake M
Int J Oncol; 2001 Jan; 18(1):89-95. PubMed ID: 11115543
[TBL] [Abstract][Full Text] [Related]
10. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M
Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.
Kido A; Krueger S; Haeckel C; Roessner A
Clin Exp Metastasis; 2003; 20(7):585-92. PubMed ID: 14669789
[TBL] [Abstract][Full Text] [Related]
13. The main neutral aminopeptidase activity of human lymphoid tumour cell lines does not originate from the aminopeptidase N-(APN; CD13) gene.
Wex T; Lendeckel U; Kähne T; Ittenson A; Frank K; Ansorge S
Biochim Biophys Acta; 1997 Feb; 1355(2):147-54. PubMed ID: 9042335
[TBL] [Abstract][Full Text] [Related]
14. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) by interferon-gamma on the HL-60 cell line.
Gabrilovac J; Breljak D; Cupić B; Ambriović-Ristov A
Life Sci; 2005 Apr; 76(23):2681-97. PubMed ID: 15792835
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies.
Ashmun RA; Shapiro LH; Look AT
Blood; 1992 Jun; 79(12):3344-9. PubMed ID: 1375850
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes.
Gabrilovac J; Cupić B; Breljak D; Zekusić M; Boranić M
Immunol Lett; 2004 Jan; 91(1):39-47. PubMed ID: 14757368
[TBL] [Abstract][Full Text] [Related]
17. Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.
Guzman-Rojas L; Rangel R; Salameh A; Edwards JK; Dondossola E; Kim YG; Saghatelian A; Giordano RJ; Kolonin MG; Staquicini FI; Koivunen E; Sidman RL; Arap W; Pasqualini R
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1637-42. PubMed ID: 22307623
[TBL] [Abstract][Full Text] [Related]
18. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
Cui SX; Zhang HL; Xu WF; Qu XJ
Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845
[TBL] [Abstract][Full Text] [Related]
19. Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
Murakami H; Yokoyama A; Kondo K; Nakanishi S; Kohno N; Miyake M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8674-9. PubMed ID: 16361553
[TBL] [Abstract][Full Text] [Related]
20. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
